BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8975352)

  • 21. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current concepts in therapy of reflux disease].
    Kirchgatterer A; Aschl G; Hinterreiter M; Stadler B; Knoflach P
    Wien Med Wochenschr; 2001; 151(11-12):266-9. PubMed ID: 11515224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2005 Dec; (14):567-81. PubMed ID: 16620423
    [No Abstract]   [Full Text] [Related]  

  • 26. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2004 Jun; (11):583-600. PubMed ID: 15652024
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic approaches in gastroesophageal reflux disease].
    Rühl A; Erckenbrecht JF
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():60-6; discussion 75-7. PubMed ID: 1972603
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies of sucralfate in reflux esophagitis. The European experience.
    Hameeteman W
    J Clin Gastroenterol; 1991; 13 Suppl 2():S16-20. PubMed ID: 1885899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualized acute treatment strategies for gastroesophageal reflux disease.
    Reynolds JC
    Scand J Gastroenterol Suppl; 1995; 213():17-24. PubMed ID: 8578239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
    Robinson M; Decktor DL; Maton PN; Sabesin S; Roufail W; Kogut D; Roberts W; McCullough A; Pardoll P; Saco L
    Aliment Pharmacol Ther; 1993 Feb; 7(1):67-73. PubMed ID: 8439639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The medical therapy of reflux oesophagitis.
    Tytgat GN; Nio CY
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The lacto-complex in the therapy of gastroesophageal reflux. Clinical and endoscopic evaluation].
    Rossini FP; Ferrari A
    Minerva Med; 1975 Apr; 66(25):1204-12. PubMed ID: 1134661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of gastroesophageal reflux disease.
    Koppelo KL; Kaplan B
    J Am Pharm Assoc (Wash); 1996 Jan; NS36(1):16-26. PubMed ID: 8835437
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathophysiology and treatment of gastro-oesophageal reflux disease.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 165():7-12; discussion 27-8. PubMed ID: 2574907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of antacids.
    Halter F
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current trends in the pharmacotherapy for gastroesophageal reflux disease.
    Hixson LJ; Kelley CL; Jones WN; Tuohy CD
    Arch Intern Med; 1992 Apr; 152(4):717-23. PubMed ID: 1558428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.
    Tolman KG; Chandramouli J; Fang JC
    Expert Opin Pharmacother; 2000 Sep; 1(6):1171-94. PubMed ID: 11249486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.